实验方法>
免疫学技术>
抗体抗原实验>Growth of Human Mast Cells From Bone Marrow and Peripheral Blood-Derived CD34+ Pluripotent Progenitor Cells
Growth of Human Mast Cells From Bone Marrow and Peripheral Blood-Derived CD34+ Pluripotent Progenitor Cells
关键词: growth human mast cells来源: 互联网
Human mast cells (HMCs) are derived from a CD34+ pluripotent progenitor cell that is Kit (CD117+), CD13+, FcεRI- and lacks lineage-specific surface markers. Bone marrow and peripheral blood are two tissue sources available for obtaining CD34+ progenitor cells from which to culture HMCs. CD34+ cells can be isolated and enriched by magnetic separation columns and stored under specific conditions until ready for use. Alternatively, enriched CD34+ cells may be immediately cultured in serum-free culture media containing recombinant human stem cell factor (rhSCF), rhIL-6, and rhIL-3 (first week only). Weekly hemidepletions and the removal of adherent cells and/or debris enables the investigator to obtain HMC cultures, identified by Wright-Giemsa and acidic toluidine blue stains, by 8–10 wk.
推荐方法
- 免疫球蛋白提取 (Immunoglobulin isolation):IgM的分离与提纯
- 免疫细胞(血液细胞)的分化
- 免疫球蛋白 M(immunoglobulin M, IgM)
- 细胞因子的命名
- Yeast Surface Display of Lamprey Variable Lymphocyte Receptors
- Reactive Oxygen Release
- Quantification of M. tuberculosis DNA in Sputum During the Treatment of Pulmonary Tuberculosis
- Genotyping Methods to Analyse Polymorphisms in Toll-Like Receptors and Disease
- Generation of TransgenicT Cells from Human CD34+Cord Blood Cells
- Bioinformatic Approaches to siRNA Selection and Optimization